Genmab A/S
NASDAQ:GMAB

Watchlist Manager
Genmab A/S Logo
Genmab A/S
NASDAQ:GMAB
Watchlist
Price: 20.56 USD 0.1% Market Closed
Market Cap: 13B USD
Have any thoughts about
Genmab A/S?
Write Note

Intrinsic Value

The intrinsic value of one GMAB stock under the Base Case scenario is 36.09 USD. Compared to the current market price of 20.56 USD, Genmab A/S is Undervalued by 43%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

GMAB Intrinsic Value
36.09 USD
Undervaluation 43%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Genmab A/S

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
GMAB
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for GMAB cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about GMAB?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Genmab A/S

Provide an overview of the primary business activities
of Genmab A/S.

What unique competitive advantages
does Genmab A/S hold over its rivals?

What risks and challenges
does Genmab A/S face in the near future?

Summarize the latest earnings call
of Genmab A/S.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Genmab A/S.

Provide P/S
for Genmab A/S.

Provide P/E
for Genmab A/S.

Provide P/OCF
for Genmab A/S.

Provide P/FCFE
for Genmab A/S.

Provide P/B
for Genmab A/S.

Provide EV/S
for Genmab A/S.

Provide EV/GP
for Genmab A/S.

Provide EV/EBITDA
for Genmab A/S.

Provide EV/EBIT
for Genmab A/S.

Provide EV/OCF
for Genmab A/S.

Provide EV/FCFF
for Genmab A/S.

Provide EV/IC
for Genmab A/S.

Show me price targets
for Genmab A/S made by professional analysts.

What are the Revenue projections
for Genmab A/S?

How accurate were the past Revenue estimates
for Genmab A/S?

What are the Net Income projections
for Genmab A/S?

How accurate were the past Net Income estimates
for Genmab A/S?

What are the EPS projections
for Genmab A/S?

How accurate were the past EPS estimates
for Genmab A/S?

What are the EBIT projections
for Genmab A/S?

How accurate were the past EBIT estimates
for Genmab A/S?

Compare the revenue forecasts
for Genmab A/S with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Genmab A/S and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Genmab A/S against its competitors.

Analyze the profit margins
(gross, operating, and net) of Genmab A/S compared to its peers.

Compare the P/E ratios
of Genmab A/S against its peers.

Discuss the investment returns and shareholder value creation
comparing Genmab A/S with its peers.

Analyze the financial leverage
of Genmab A/S compared to its main competitors.

Show all profitability ratios
for Genmab A/S.

Provide ROE
for Genmab A/S.

Provide ROA
for Genmab A/S.

Provide ROIC
for Genmab A/S.

Provide ROCE
for Genmab A/S.

Provide Gross Margin
for Genmab A/S.

Provide Operating Margin
for Genmab A/S.

Provide Net Margin
for Genmab A/S.

Provide FCF Margin
for Genmab A/S.

Show all solvency ratios
for Genmab A/S.

Provide D/E Ratio
for Genmab A/S.

Provide D/A Ratio
for Genmab A/S.

Provide Interest Coverage Ratio
for Genmab A/S.

Provide Altman Z-Score Ratio
for Genmab A/S.

Provide Quick Ratio
for Genmab A/S.

Provide Current Ratio
for Genmab A/S.

Provide Cash Ratio
for Genmab A/S.

What is the historical Revenue growth
over the last 5 years for Genmab A/S?

What is the historical Net Income growth
over the last 5 years for Genmab A/S?

What is the current Free Cash Flow
of Genmab A/S?

Discuss the annual earnings per share (EPS)
trend over the past five years for Genmab A/S.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Genmab A/S

Current Assets 27.9B
Cash & Short-Term Investments 21.1B
Receivables 6.7B
Other Current Assets 62m
Non-Current Assets 18B
Long-Term Investments 228m
PP&E 1.9B
Intangibles 14.9B
Other Non-Current Assets 960m
Current Liabilities 5.3B
Other Current Liabilities 5.3B
Non-Current Liabilities 3.8B
Long-Term Debt 937m
Other Non-Current Liabilities 2.9B
Efficiency

Free Cash Flow Analysis
Genmab A/S

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Genmab A/S

Revenue
21.5B DKK
Cost of Revenue
-985m DKK
Gross Profit
20.5B DKK
Operating Expenses
-13.5B DKK
Operating Income
7.1B DKK
Other Expenses
765m DKK
Net Income
7.8B DKK
Fundamental Scores

GMAB Profitability Score
Profitability Due Diligence

Genmab A/S's profitability score is 79/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROIC
Positive Free Cash Flow
Positive Gross Profit
Exceptional 3-Years Revenue Growth
79/100
Profitability
Score

Genmab A/S's profitability score is 79/100. The higher the profitability score, the more profitable the company is.

GMAB Solvency Score
Solvency Due Diligence

Genmab A/S's solvency score is 99/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
99/100
Solvency
Score

Genmab A/S's solvency score is 99/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

GMAB Price Targets Summary
Genmab A/S

Wall Street analysts forecast GMAB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GMAB is 32.92 USD with a low forecast of 15.42 USD and a high forecast of 47.6 USD.

Lowest
Price Target
15.42 USD
25% Downside
Average
Price Target
32.92 USD
60% Upside
Highest
Price Target
47.6 USD
132% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Genmab A/S
does not pay dividends
Shareholder Yield

Current shareholder yield for GMAB is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

GMAB News

What is the Intrinsic Value of one GMAB stock?

The intrinsic value of one GMAB stock under the Base Case scenario is 36.09 USD.

Is GMAB stock undervalued or overvalued?

Compared to the current market price of 20.56 USD, Genmab A/S is Undervalued by 43%.

Back to Top